Iron chelation in early Parkinson’s disease

Related Articles:

• The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
• The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s.  It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
• Iron chelation in early Parkinson's disease March 17, 2023 Lancet Neurol. 2023 Apr;22(4):290-291. doi: 10.1016/S1474-4422(23)00039-X.NO ABSTRACTPMID:36931794 | DOI:10.1016/S1474-4422(23)00039-X
• Iron chelation in early Parkinson's disease March 17, 2023 Lancet Neurol. 2023 Apr;22(4):290-291. doi: 10.1016/S1474-4422(23)00039-X.NO ABSTRACTPMID:36931794 | DOI:10.1016/S1474-4422(23)00039-X
• Iron chelation in early Parkinson's disease March 17, 2023 Lancet Neurol. 2023 Apr;22(4):290-291. doi: 10.1016/S1474-4422(23)00039-X.NO ABSTRACTPMID:36931794 | DOI:10.1016/S1474-4422(23)00039-X
• Iron chelation in early Parkinson's disease March 17, 2023 Lancet Neurol. 2023 Apr;22(4):290-291. doi: 10.1016/S1474-4422(23)00039-X.NO ABSTRACTPMID:36931794 | DOI:10.1016/S1474-4422(23)00039-X
• The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
• Monthly Research Review – October 2022 October 31, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during October 2022. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
• The radiologist at a Parkinson’s conference October 24, 2022 # # # # In 2015, a woman with dementia was sitting in hospice care, wheelchair-bound and largely non-communicative. As part of a research project, she was given repeated computed tomography (CT) scans of her brain. The effect of this seemingly harmless treatment was rather astonishing, and it has led to more research exploring the effect of low dose ionizing…
• Animals in Parkinson's research October 22, 2022 Saturday 22 October 2022  Continuing with the theme of animal models, here is an essay I wrote as part of my MSc neuroscience about the use of animals in Parkinson’s research. Many people, myself included, feel uncomfortable about the use of animals in brain research, an issue for which there are no easy answers. There is quite a bit of…
• Monthly Research Review – November 2022 November 30, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2022. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
• Excess Iron in Brain Cells Worsens Parkinson’s Symptoms, Mouse Study Shows January 9, 2020 While excess iron in the brain often accompanies Parkinson’s disease, it remains unknown whether the iron overload actually causes the neurodegenerative disorder or is merely a product of it. New research now sheds greater light on the role that iron plays in the development of a Parkinson’s disease model. It also illustrates how certain cells regulate the brain’s response to…
• Immunomodulating Activity of an Extract from Ashwagandha: Implications for Treatment of Parkinson’s March 15, 2023 “The mind, in addition to medicine, has powers to turn the immune system around.” Jonas Salk “As you begin to heal the inner you, you alter your immune system.” Wayne Dyer Introduction: The current blog post is focused on reviewing an immunomodulating action of an extract from Ashwagandha. Furthermore, I will comment on the use of Ashwagandha for treating Parkinson’s.…
• A randomized single and multiple ascending dose study in healthy volunteers of LTI-291, a centrally penetrant glucocerebrosidase activator. February 13, 2021 Related ArticlesA randomized single and multiple ascending dose study in healthy volunteers of LTI-291, a centrally penetrant glucocerebrosidase activator. Br J Clin Pharmacol. 2021 Feb 11;: Authors: den Heijer JM, Kruithof AC, van Amerongen G, de Kam ML, Thijssen E, Grievink HW, Moerland M, Walker M, Been K, Skerlj R, Justman C, Dudgeon L, Lansbury P, Cullen VC, Hilt DC,…
• Parkinson’s and Autoimmunity January 26, 2023 “I am always doing that which I cannot do, in order that I may learn how to do it.” Pablo Picasso “We have more possibilities available in each moment than we realize.” Nhat Hanh Précis: This post exists because I received a note from a reader concerned about using a substance that potentially was an immune enhancer, coupled with the…
• The trans-omics of -omics November 18, 2022 # # # # “Precision medicine” is an emerging model of therapeutic intervention in which treatment options are tailored to a specific subtype of a condition or even on an individual patient-based metric that involves an intergrated analysis of his/her comprehensive “-omics” data. Many different methods of stratifying patients have been proposed and many of them involve adding the word…
• Comparison Between Hesperidin, Coumarin, and Deferoxamine Iron Chelation and Antioxidant Activity Against Excessive Iron in the Iron Overloaded Mice February 18, 2022 Front Neurosci. 2022 Feb 1;15:811080. doi: 10.3389/fnins.2021.811080. eCollection 2021.ABSTRACTOBJECTIVE: Iron accumulation in the brain leads to the development of Alzheimer's and Parkinson's diseases. Nowadays, iron chelation therapy is the best way to decrease the side effects of iron and amyloid plaques accumulation. Iron chelators are commonly used for the treatment of Alzheimer's disease. Previous studies have shown that natural products…
• Comparison Between Hesperidin, Coumarin, and Deferoxamine Iron Chelation and Antioxidant Activity Against Excessive Iron in the Iron Overloaded Mice February 18, 2022 Front Neurosci. 2022 Feb 1;15:811080. doi: 10.3389/fnins.2021.811080. eCollection 2021.ABSTRACTOBJECTIVE: Iron accumulation in the brain leads to the development of Alzheimer's and Parkinson's diseases. Nowadays, iron chelation therapy is the best way to decrease the side effects of iron and amyloid plaques accumulation. Iron chelators are commonly used for the treatment of Alzheimer's disease. Previous studies have shown that natural products…
• Comparison Between Hesperidin, Coumarin, and Deferoxamine Iron Chelation and Antioxidant Activity Against Excessive Iron in the Iron Overloaded Mice February 18, 2022 Front Neurosci. 2022 Feb 1;15:811080. doi: 10.3389/fnins.2021.811080. eCollection 2021.ABSTRACTOBJECTIVE: Iron accumulation in the brain leads to the development of Alzheimer's and Parkinson's diseases. Nowadays, iron chelation therapy is the best way to decrease the side effects of iron and amyloid plaques accumulation. Iron chelators are commonly used for the treatment of Alzheimer's disease. Previous studies have shown that natural products…
• Comparison Between Hesperidin, Coumarin, and Deferoxamine Iron Chelation and Antioxidant Activity Against Excessive Iron in the Iron Overloaded Mice February 18, 2022 Front Neurosci. 2022 Feb 1;15:811080. doi: 10.3389/fnins.2021.811080. eCollection 2021.ABSTRACTOBJECTIVE: Iron accumulation in the brain leads to the development of Alzheimer's and Parkinson's diseases. Nowadays, iron chelation therapy is the best way to decrease the side effects of iron and amyloid plaques accumulation. Iron chelators are commonly used for the treatment of Alzheimer's disease. Previous studies have shown that natural products…
• Comparison Between Hesperidin, Coumarin, and Deferoxamine Iron Chelation and Antioxidant Activity Against Excessive Iron in the Iron Overloaded Mice February 18, 2022 Front Neurosci. 2022 Feb 1;15:811080. doi: 10.3389/fnins.2021.811080. eCollection 2021.ABSTRACTOBJECTIVE: Iron accumulation in the brain leads to the development of Alzheimer's and Parkinson's diseases. Nowadays, iron chelation therapy is the best way to decrease the side effects of iron and amyloid plaques accumulation. Iron chelators are commonly used for the treatment of Alzheimer's disease. Previous studies have shown that natural products…
• Comparison Between Hesperidin, Coumarin, and Deferoxamine Iron Chelation and Antioxidant Activity Against Excessive Iron in the Iron Overloaded Mice February 18, 2022 Front Neurosci. 2022 Feb 1;15:811080. doi: 10.3389/fnins.2021.811080. eCollection 2021.ABSTRACTOBJECTIVE: Iron accumulation in the brain leads to the development of Alzheimer's and Parkinson's diseases. Nowadays, iron chelation therapy is the best way to decrease the side effects of iron and amyloid plaques accumulation. Iron chelators are commonly used for the treatment of Alzheimer's disease. Previous studies have shown that natural products…